Jack Anders - 01 Sep 2022 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role: Chief Financial Officer
Signature: /s/ Jack Anders
Issuer symbol: RVMD
Transactions as of: 01 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Sep 2022, 16:18:21 UTC
Previous filing: 22 Jun 2022
Next filing: 21 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVMD	Common Stock	Award	$0	+10,000	+49%	$0.000000	30,405	01 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RVMD	Stock Option (Right to Buy)	Award	$0	+35,000		$0.000000	35,000	01 Sep 2022	Common Stock	35,000	$21.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 25,964 restricted stock units.
F2	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 1, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Content

Includes 25,964 restricted stock units.

One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 1, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.